abstract |
The present invention relates to imidazo [1,2-a] pyrimidine derivatives useful for treating cell proliferative diseases, treating diseases associated with MET activity, and inhibiting the receptor tyrosine kinase MET. . The invention also relates to compositions comprising these compounds and methods of using them to treat mammalian cancer. |